Menu
Back to Journals » OncoTargets and Therapy » Volume 14
MicroRNA-675 Directly Targets MAPK1 to Suppress the Oncogenicity of Papillary Thyroid Cancer and is Sponged by Long Non-Coding RNA RMRP [Retraction]
Wang J, Xiao T, Zhao M. Onco Targets Ther. 2019;12:7307–7321.
The Editor and Publisher of OncoTargets and Therapy wish to retract the published article. Concerns were raised over the alleged image duplication of images between Figures 3F and 4A, and the alleged duplication of images in Figure 8A with similar images from unrelated articles, specifically:
- Figure 3F, panel GAPDH appears to have been duplicated with a similar image in Figure 4A, panel GAPDH.
- Figure 8A appears to have been duplicated with a similar image in Figure 7A from Zhang et al, 2019 (https://doi.org/10.3892/ijo.2019.4765).
The authors did not respond to our queries and the Editor determined the findings of the study were no longer valid and advised for the article to be retracted.
Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
© 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.